BIOLASE, Inc.

BIOL · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$21-$29-$16-$17
Dep. & Amort.$3$0$0$0
Deferred Tax$0$0-$4-$2
Stock-Based Comp.$1$2$2$3
Change in WC$1-$5$0$2
Other Non-Cash$1$4$1$0
Operating Cash Flow-$14-$27-$17-$13
Investing Activities
PP&E Inv.-$1-$4-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$4$0$0
Investing Cash Flow-$1-$4-$1-$0
Financing Activities
Debt Repay.-$0-$1$0$2
Stock Issued$10$6$14$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$8$0$16$15
Financing Cash Flow$17$5$30$24
Forex Effect$0-$0-$0$0
Net Chg. in Cash$2-$26$12$12
Supplemental Information
Beg. Cash$4$30$18$6
End Cash$7$4$30$18
Free Cash Flow-$15-$30-$17-$13